NewEdge Wealth LLC Decreases Stock Position in Synopsys, Inc. $SNPS

NewEdge Wealth LLC lessened its stake in shares of Synopsys, Inc. (NASDAQ:SNPS) by 72.7% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,399 shares of the semiconductor company’s stock after selling 6,400 shares during the period. NewEdge Wealth LLC’s holdings in Synopsys were worth $951,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently made changes to their positions in the company. Sankala Group LLC bought a new stake in shares of Synopsys in the fourth quarter worth about $25,000. Thurston Springer Miller Herd & Titak Inc. bought a new position in Synopsys during the fourth quarter valued at approximately $28,000. Caitong International Asset Management Co. Ltd bought a new position in Synopsys during the fourth quarter valued at approximately $28,000. Atlas Capital Advisors Inc. purchased a new position in Synopsys during the 4th quarter valued at approximately $32,000. Finally, Geneos Wealth Management Inc. grew its holdings in Synopsys by 151.5% during the 1st quarter. Geneos Wealth Management Inc. now owns 83 shares of the semiconductor company’s stock valued at $33,000 after buying an additional 50 shares in the last quarter. Hedge funds and other institutional investors own 85.47% of the company’s stock.

Analyst Ratings Changes

A number of analysts have issued reports on SNPS shares. Robert W. Baird set a $558.00 price objective on Synopsys in a research note on Thursday, May 28th. Berenberg Bank set a $633.00 target price on shares of Synopsys in a report on Wednesday, May 27th. Weiss Ratings restated a “hold (c-)” rating on shares of Synopsys in a research report on Monday, June 8th. Citigroup upped their price target on shares of Synopsys from $600.00 to $610.00 and gave the company a “buy” rating in a research note on Thursday, May 28th. Finally, Needham & Company LLC reiterated a “buy” rating and set a $580.00 price objective on shares of Synopsys in a research report on Thursday, May 28th. Two analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating, five have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $570.06.

Insiders Place Their Bets

In other Synopsys news, CFO Shelagh Glaser sold 3,394 shares of the business’s stock in a transaction on Friday, June 12th. The shares were sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the transaction, the chief financial officer owned 14,358 shares in the company, valued at $6,461,387.16. The trade was a 19.12% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the stock in a transaction on Monday, June 15th. The shares were sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the completion of the sale, the chief executive officer directly owned 75,020 shares in the company, valued at approximately $34,431,179.20. This represents a 16.29% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.56% of the stock is owned by company insiders.

Key Stories Impacting Synopsys

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: Synopsys introduced autonomous, agentic AI EDA workflows developed with Microsoft and used by AMD. The workflows, available for evaluation through Microsoft Discovery, are designed to automate portions of the chip-design process from specifications through silicon, potentially increasing demand for Synopsys’ software and services. Synopsys Advances Agentic AI Chip Design with AMD and Microsoft
• Positive Sentiment: The company expanded its collaboration with Intel Foundry by certifying AI-powered EDA flows for Intel’s 14A process. Synopsys also highlighted multiphysics analysis, 3DIC support for Intel’s EMIB packaging and IP for PCIe 7.0, 224G SerDes and USB 4, which could help customers accelerate advanced multi-die designs and improve Synopsys’ competitive positioning. Synopsys and Intel Foundry Fast-Track Customer Readiness
• Positive Sentiment: Synopsys demonstrated autonomous engineering workflows developed with NVIDIA technology, including a chip-verification agent reported to deliver up to 50-times faster time to validated RTL and 20% greater coverage. The company also cited more than 20 GPU-accelerated EDA and multiphysics products, reinforcing its exposure to AI-driven engineering productivity. Synopsys Autonomous Engineering Workflows With NVIDIA
• Neutral Sentiment: Investors are also looking ahead to Synopsys’ fiscal third-quarter results, scheduled for August 26. Analysts expect year-over-year earnings growth, while the company’s fiscal 2026 guidance remains constructive. However, the stock trades below its 50-day and 200-day moving averages, leaving execution and earnings confirmation important.
• Negative Sentiment: Recent disclosures indicate that Synopsys’ CEO and CFO sold shares during the past six months. These transactions may create a modest sentiment overhang, although they do not directly alter the company’s operating outlook. Why Synopsys Stock Is Up Today

Synopsys Trading Up 4.2%

Shares of SNPS stock opened at $388.99 on Tuesday. Synopsys, Inc. has a 1 year low of $366.00 and a 1 year high of $651.73. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.32. The stock’s 50 day simple moving average is $453.94 and its two-hundred day simple moving average is $454.14. The company has a market cap of $74.48 billion, a PE ratio of 90.04, a price-to-earnings-growth ratio of 2.19 and a beta of 1.22.

Synopsys (NASDAQ:SNPS) last posted its quarterly earnings data on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.15 by $0.20. The business had revenue of $2.28 billion during the quarter, compared to analyst estimates of $2.25 billion. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The company’s revenue for the quarter was up 41.9% on a year-over-year basis. During the same period last year, the company earned $3.67 EPS. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Research analysts predict that Synopsys, Inc. will post 10.65 earnings per share for the current year.

About Synopsys

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.